how many people are using glp-1 Products - Data Briefs - Number 537 How Many Americans Are on

After 52 weeks of once weekly Zepbound (10 or 15 mg) or placebo, participants on Lillys drug experienced a statistically significant and clinically meaningful reduction in apnea or hypopnea events

Although data from early phase trials suggest that retatrutide is well tolerated with a similar adverse event profile to GLP-1 RAs, additional research assessing long-term safety and efficacy of retatrutide in people living with obesity and/or T2D (including cardiovascular outcomes) is awaited over the next five years

From November 2025 to now (May 2026), Im back to my pre-pregnancy weight, I feel more energized, and Im not constantly dealing with food noise that tells me to demolish an entire bag of Doritos in between back-to-back work calls

[DOI] [PubMed] [Google Scholar] 93.Enebo LB, Berthelsen KK, Kankam M, Lund MT, Rubino DM, Satylganova A, Lau DCW

"Look, you see cooked shrimp is under those items," she says

Unlike other medications that focus on temporary appetite reduction, semaglutide GLP-1 works by mimicking the GLP-1 hormone, which helps regulate hunger and slow gastric emptying